Gene · 8519
Papers2,758
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,758
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Single-cell and bulk transcriptomic analyses define an IFI27-centered interferon-response epithelial state in bladder cancer and its transcriptional response to irradiation. | Front Cell Dev Biol | 2026 | 42798643 | PubTator, text mining | PubMed |
| Transcriptomic characterization of transitional B cells reveals four subsets with perturbed activation profiles in scleroderma. | iScience | 2026 | 42774868 | PubTator, text mining | PubMed |
| Identification of Critical Genes for Recurrent Aphthous Ulcer by Transcriptome Data Analysis and Mendelian Randomization. | Oral Health Prev Dent | 2026 | 42714320 | PubTator, text mining | PubMed |
| IFITM1 enhances anti-tumor function of unconventional TCRαβ double negative T cells by upregulating mitophagy. | Sci China Life Sci | 2026 | 42667541 | PubTator, text mining | PubMed |
| A Multi-Layered Proteogenomic Framework for the Prioritization of Cell Surface Therapeutic Targets: Proof-of-Concept for Metastatic Colorectal Cancer. | Cancers (Basel) | 2026 | 42649884 | PubTator, text mining | PubMed |
| Systems pharmacology reveals type I interferon and myeloid-like B cell reprogramming as candidate druggable axes in antiphospholipid syndrome. | PLoS One | 2026 | 42647509 | PubTator, text mining | PubMed |
| Interferon-induced transmembrane (IFITM) proteins at the tumour-immune interface: A four-axis framework for their context-dependent roles. | Clin Transl Med | 2026 | 42613969 | PubTator, text mining | PubMed |
| Retraction notice to "The role and mechanism of IFITM1 in developing acquired cisplatin resistance in small cell lung cancer" [Heliyon 10 (2024) e30806]. | Heliyon | 2026 | 42581850 | PubTator, text mining | PubMed |
| Screening for candidate genes and cell populations associated with atherosclerotic calcification using single-cell RNA sequencing. | Mamm Genome | 2026 | 42581084 | PubTator, text mining | PubMed |
| Determinants of response to neoadjuvant chemotherapy in breast cancer: Integrated roles of immune pathways, DNA damage response, and cell cycle regulators. | Mol Biol Rep | 2026 | 42530655 | PubTator, text mining | PubMed |
| Single-cell sequencing reveals an immunotherapy-relevant IFITM1-marked epithelial interferon state in nasopharyngeal carcinoma. | Transl Oncol | 2026 | 42468141 | PubTator, text mining | PubMed |
| DNA methylation signatures distinguish extranodal NK/T-cell lymphoma and EBV-positive nodal T/NK-cell lymphoma and identify prognostic subgroups. | Leukemia | 2026 | 42457877 | PubTator, text mining | PubMed |
| CD4+ T cell signature in long COVID: insights from an unvaccinated cohort. | Front Immunol | 2026 | 42445202 | PubTator, text mining | PubMed |
| LncRNA AK093407-IFITM1- Wnt/β-catenin regulation axis in colorectal cancer. | Sci Prog | 2026 | 42444619 | PubTator, text mining | PubMed |
| Gene duplication and retrotransposition diversify the antiviral repertoire of macaque IFITM proteins. | bioRxiv | 2026 | 42327289 | PubTator, text mining | PubMed |
| Targeting RELA and STAT3 regulates TNFRSF10A-mediated apoptosis in a novel apoptosis-based prognostic model for clear cell renal cell carcinoma. | World J Surg Oncol | 2026 | 42324555 | PubTator, text mining | PubMed |
| Integrative transcriptomic and systems biology analysis of public SLE datasets identifies immune regulatory pathways. | J Comput Aided Mol Des | 2026 | 42295464 | PubTator, text mining | PubMed |
| Insulin Signalling-Inducible IFITM1 Promotes Multiple Myeloma Progression and Bortezomib Resistance. | J Cell Mol Med | 2026 | 42286874 | PubTator, text mining | PubMed |
| Aloe emodin isolated from Cassiae semen upregulates IFITM1 to suppress hepatitis B virus replication via the interferon signaling pathway. | mSphere | 2026 | 42274254 | PubTator, text mining | PubMed |
| IFITM1 and IFITM3 cooperate to restrict virus entry in endolysosomes. | J Virol | 2026 | 42262132 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8519/papers